These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25733327)

  • 1. Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis.
    Shen L; Peng H; Peng R; Fan Q; Zhao S; Xu D; Morisseau C; Chiamvimonvat N; Hammock BD
    Atherosclerosis; 2015 Apr; 239(2):557-65. PubMed ID: 25733327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potent soluble epoxide hydrolase inhibitor, t-AUCB, modulates cholesterol balance and oxidized low density lipoprotein metabolism in adipocytes in vitro.
    Shen L; Peng H; Zhao S; Xu D
    Biol Chem; 2014 Apr; 395(4):443-51. PubMed ID: 24225128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phosphatase activity of soluble epoxide hydrolase regulates ATP-binding cassette transporter-A1-dependent cholesterol efflux.
    Lien CC; Chen CH; Lee YM; Guo BC; Cheng LC; Pan CC; Shyue SK; Lee TS
    J Cell Mol Med; 2019 Oct; 23(10):6611-6621. PubMed ID: 31436906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
    Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Soluble Epoxide Hydrolase in Macrophages Ameliorates the Formation of Foam Cells　- Role of Heme Oxygenase-1.
    Peng H; Tang J; Zhao S; Shen L; Xu D
    Circ J; 2019 Nov; 83(12):2555-2566. PubMed ID: 31666457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
    Roche C; Besnier M; Cassel R; Harouki N; Coquerel D; Guerrot D; Nicol L; Loizon E; Remy-Jouet I; Morisseau C; Mulder P; Ouvrard-Pascaud A; Madec AM; Richard V; Bellien J
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1020-9. PubMed ID: 25724490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Soluble epoxide hydrolase inhibitor t-AUCB ameliorates ox-LDL induced conversion of macrophages into foam cells through activating the PPARγ-ABCA1 pathway].
    Zhao TT; Peng R; Shen L; Zhao X; Xu DY; Zhao SP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Mar; 40(3):248-52. PubMed ID: 22801272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction.
    Xu DY; Davis BB; Wang ZH; Zhao SP; Wasti B; Liu ZL; Li N; Morisseau C; Chiamvimonvat N; Hammock BD
    Int J Cardiol; 2013 Aug; 167(4):1298-304. PubMed ID: 22525341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.
    Elmarakby AA; Faulkner J; Pye C; Rouch K; Alhashim A; Maddipati KR; Baban B
    Clin Sci (Lond); 2013 Oct; 125(7):349-59. PubMed ID: 23611540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
    Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNAs in lipoprotein metabolism and cardiometabolic disorders.
    Rotllan N; Price N; Pati P; Goedeke L; Fernández-Hernando C
    Atherosclerosis; 2016 Mar; 246():352-60. PubMed ID: 26828754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probucol-Oxidized Products, Spiroquinone and Diphenoquinone, Promote Reverse Cholesterol Transport in Mice.
    Yakushiji E; Ayaori M; Nishida T; Shiotani K; Takiguchi S; Nakaya K; Uto-Kondo H; Ogura M; Sasaki M; Yogo M; Komatsu T; Lu R; Yokoyama S; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):591-7. PubMed ID: 26848156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sortilin promotes macrophage cholesterol accumulation and aortic atherosclerosis through lysosomal degradation of ATP-binding cassette transporter A1 protein.
    Lv Y; Yang J; Gao A; Sun S; Zheng X; Chen X; Wan W; Tang C; Xie W; Li S; Guo D; Peng T; Zhao G; Zhong L
    Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):471-483. PubMed ID: 30950489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ABCA1 protein degradation promotes HDL cholesterol efflux capacity and RCT and reduces atherosclerosis in mice.
    Huang L; Fan B; Ma A; Shaul PW; Zhu H
    J Lipid Res; 2015 May; 56(5):986-97. PubMed ID: 25761370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.
    Rayner KJ; Sheedy FJ; Esau CC; Hussain FN; Temel RE; Parathath S; van Gils JM; Rayner AJ; Chang AN; Suarez Y; Fernandez-Hernando C; Fisher EA; Moore KJ
    J Clin Invest; 2011 Jul; 121(7):2921-31. PubMed ID: 21646721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(-/-) mice.
    Zhang W; Yang AL; Liao J; Li H; Dong H; Chung YT; Bai H; Matkowskyj KA; Hammock BD; Yang GY
    Dig Dis Sci; 2012 Oct; 57(10):2580-91. PubMed ID: 22588244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.
    Chaudhary KR; Abukhashim M; Hwang SH; Hammock BD; Seubert JM
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):67-73. PubMed ID: 19834332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport.
    Yamamoto S; Tanigawa H; Li X; Komaru Y; Billheimer JT; Rader DJ
    Circulation; 2011 Sep; 124(12):1382-90. PubMed ID: 21859969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr(-/-) mice.
    Li D; Liu Y; Zhang X; Lv H; Pang W; Sun X; Gan LM; Hammock BD; Ai D; Zhu Y
    J Mol Cell Cardiol; 2016 Sep; 98():128-37. PubMed ID: 27496380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.